Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Neutropenia Clinical Trials


A listing of Neutropenia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Glendale : Arizona Center for Cancer Care

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Scottdale : Desert Springs Cancer Care

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Arkansas

Jonesboro : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

California

Corona : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Fresno : California Cancer Associates for Research and Excellence

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Highland : Beaver Medical Group

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Orange : Hematology Oncology Medical Group

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Florida

Boynton Beach : Thomas Niederman, M.D., Ph.D

Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients

Kentucky

Mt Sterling : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Maryland

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Michigan

Detroit : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

New York

New York : Memorial Sloan-Kettering Cancer Center

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Rochester : University of Rochester Medical Center

Daptomycin Versus Placebo in Patients With Neutropenia and Fever

North Dakota

Bismarck : St. Alexius Medical Center

A study for patients with breast cancer who are eligible for chemotherapy. Neulasta® will also be used in this study as a comparator to the investigational medication for the treatment of Neutropenia

View More »

Bismarck : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Oregon

Eugene : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Tennessee

Germantown : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Virginia

Newport News : Sandoz Investigational Site

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Brazil

Curitiba : Investigational Site Number 004

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Porto Alegre : Investigational Site Number 005

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Santo Andre : Investigational Site Number 001

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

São Paulo : Investigational Site Number 002

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

China

Beijing : Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

Shanghai : Shanghai Pulmonary Hospital

A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

Czech Republic

Ves pod Plesi 110 : Insitut Onkologie a Rehabilitaca na Plesi

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Znojmo : Nemocnice Znojmo

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

France

Paris : Hôpital Européen Georges Pompidou - Service Oncologie Médicale

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Germany

Hamburg : Universitaetsklinik Hamburg-Eppendorf, Med. Klinik II Onkologie, Haematologie

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Hungary

Nyiregyhaza : Josa Andras Oktato Korhaz Nonprofit Kft

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Italy

Torino : Azienda Ospedaliero Universitaria "San Giovanni Battista di Torino"

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Japan

Nagoya : Nagoya University Graduate School of Medicine

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Korea, Republic of

Busan :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Daegu :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Daejeon :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Goyang :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Hwasun :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

View More »

Seoul :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Seoul : Korea University GURO hospital

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Suwon :

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Latvia

Daugavpils : Daugavpils Regional Hospital

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Poland

Bydgoszcz :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Gdansk :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Lublin :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Lublin : SPSK1 Klinika Hematologii

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Romania

Bucuresti : Centrul de Diagnostic si Tratament Euromedic Fundeni

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Jud. Bacau :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Suceava :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Timisoara :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Russian Federation

Chelyabinsk : State Medical-Prophylactic Institution SMPI Reginal Clinical Oncological Dispensary

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Magnitogorsk : State Healthcare Institution SHI Regional Oncological Dispensary

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Moscow Area :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Pyatigorsk : State Healthcare Institution SHI Pyatigorsk Oncological Dispensary

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Saint-Petersburg : Non-State Healthcare Institution NSHI

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Slovakia

Kosice : Oddelenie klinickej onkologie, Vyvhodoslovensky onkologicky ustav

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Spain

Barcelona : Hospital Clinic i Provincial de Barcelona

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Switzerland

Genolier : IMO Clinique de Genolier

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Ukraine

Dnipropetrovsk :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Uzhorod :

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

United Kingdom

Rotherham : The Rotherham NHS Foundation Trust - Dept. of Haematology

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor